Advanced solid tumor Trials in Guangzhou, China
Conditions / Advanced solid tumor / Guangzhou, China
Advanced solid tumor has been the subject of sustained clinical investigation across multiple research sites.
68 total trials for this combination
Showing top 10 of 68 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05434234 | A Study of YL201 in Patients With Advanced Solid Tumors | RECRUITING | PHASE1/PHASE2 |
| NCT04083976 | A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Gene Alterations | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT06253130 | A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors | RECRUITING | PHASE1/PHASE2 |
| NCT04805307 | Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901 | COMPLETED | PHASE1 |
| NCT06257264 | A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors | RECRUITING | — |
| NCT06172478 | A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors | RECRUITING | PHASE2 |
| NCT06253195 | BGB-43395 Alone or as Part of Combination Therapies in Chinese Participants With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT07222267 | An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors | RECRUITING | — |
| NCT06589596 | An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors | RECRUITING | PHASE1 |
| NCT06120283 | BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors | RECRUITING | — |